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CytoskeletonA diminution in the order of membrane lipids, which occurs during apoptosis, has been shown to correlate
with increased membrane susceptibility to hydrolysis by secretory phospholipase A2. Studies with artiﬁcial
membranes, however, have demonstrated that the relationship between membrane order and hydrolysis is
more complex than suggested thus far by cell studies. To better resolve this relationship, this study focused on
comparisons between increasing temperature and calcium ionophore as means of decreasing membrane order
in S49 cells. Although these two treatments caused comparable changes in apparentmembrane order as detected
by steady-state ﬂuorescence measurements, only ionophore treatment enhanced phospholipase activity. Experi-
ments with exogenously-added phosphatidylserine indicated that the difference was not due to the presence of
that anionic phospholipid in the outer membrane leaﬂet. Instead, analysis of the equilibration kinetics of various
cationicmembrane probes revealed that the difference could relate to the spacing ofmembrane lipids. Speciﬁcally,
ionophore treatment increased that spacingwhile temperature only affected overallmembrane order and ﬂuidity.
To consider the possibility that the distinction with ionophore might relate to the actin cytoskeleton, cells were
stained with phalloidin and imaged via confocal microscopy. Ionophore caused disruption of actin ﬁbers while
increased temperature did not. This apparent connection between membrane hydrolysis and the cytoskeleton
was further corroborated by examining the relationship among these events during apoptosis stimulated by
thapsigargin.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Prior studies have investigated the role of biophysical alterations
to the plasma membrane that govern its susceptibility to hydrolysis
by secretory phospholipase A2 (sPLA2). Environment-sensitive ﬂuo-
rescent membrane probes such as merocyanine 540, Laurdan,
diphenylhexatriene derivatives, and Patman have been used to detect
changes in lipid order that correlate temporally and quantitatively
with susceptibility [1–6]. In lymphocytes, reductions in lipid order con-
sistently correlate with conditions that render the cells vulnerable to
sPLA2[1,2,6,7]. This apparent reduction in lipid order has been detected
only by probes sensitive to the head-group region of themembrane and
have been quantiﬁed from steady-state measurements of generalized
polarization (GP) of the naphthalene derivatives (Laurdan and Patman)), cougarmurri@gmail.com
ss@gmail.com (E. Moss),
ail.com (J. Nelson),
Bell).or probe anisotropy [1,2,6,7]. However, experiments with artiﬁcial
bilayers and human erythrocytes have demonstrated that the relation-
ship betweenmembrane order and sPLA2 activity is more complex than
implied by the results from nucleated cells. For example, under some
conditions, raising the experimental temperature reduces the order of
liposome membranes and yields the same changes in probe steady-
state ﬂuorescence observed in cells, yet the rate of hydrolysis by sPLA2
is not affected [8–10]. In erythrocytes, conditions that promote hydroly-
sis actually increase the average lipid order, but in a way that enhances
the structural diversity in the membrane. Hydrolysis by sPLA2 appears
to localize at boundaries along regions of that diversity [3,4,11].
Hence, if membrane lipid order is relevant to the activity of sPLA2,
there must be additional information about those properties that can-
not be discerned from the anisotropy or GP of these probes. Recent
studies suggested that monitoring the pre-steady-state equilibration
of Patmanmay provide that additional information. Patman is an analog
of Laurdan that contains a trimethylammonium group attached to the
naphthalene moiety to minimize transbilayer migration and a two-
carbon extension of the aliphatic tail to retain the probe in the mem-
brane [12]. Speciﬁcally, analysis of Patman kinetics distinguished subtle
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activity is enhanced [6] compared to those in artiﬁcial membranes that
do not affect hydrolysis [9]. The results of this comparison supported
the hypothesis that sPLA2 activity is promoted by changes in membrane
order onlywhen those changes facilitatemigration of phospholipidmol-
ecules perpendicular to the plane of the bilayer [6,13,14]. Consequently,
it was proposed that quantifying the kinetics of Patman equilibration
in addition to measuring its end-point GP can be an effective tool for
detecting these subtleties of membrane order.
This study was designed to test this hypothesis and proposal in
cells without relying on artiﬁcial bilayers. This was accomplished by
comparing two experimental conditions that produce the same changes
in membrane properties detected by the end-point ﬂuorescence of
environment-sensitive membrane probes yet differ in their ability to
stimulate hydrolysis by sPLA2. A known paradigm for producing chang-
es in membrane properties that induce hydrolysis by sPLA2 is cellular
apoptosis [1,2,6,15]. In this study, the calcium ionophore ionomycin
was chosen to induce cell death because its effects are rapid, uniform,
and synchronous [1]. In order to produce changes in steady-state
probe ﬂuorescencewithout stimulating sPLA2 activity, sample tempera-
ture was manipulated. Comparison of these two treatments was then
used to clarify the nature of the relationship between membrane phys-
ical properties and sPLA2 activity in cells.
2. Materials and methods
2.1. Reagents
Monomeric aspartate-49 sPLA2 from the venom of Agkistrodon
piscivorus piscivorus (AppD49) was isolated and prepared as de-
scribed [16]. Ionomycin, 1-(4-trimethylammoniumphenyl)-6-phe-
nyl-1,3,5-hexatriene (TMA-DPH), acrylodan-labeled fatty acid-
binding protein (ADIFAB), 6-palmitoyl-2-[[2-(trimethylammonio)
ethyl]-methylamino]naphthalene chloride (Patman), merocyanine
540 (MC540), and phalloidin and annexin V conjugates with Alexa
Fluor® 488 were purchased from Life Technologies (Grand Island,
NY). Thapsigargin (TG) was acquired from Life Technologies or
Enzo Life Sciences (Plymouth Meeting, PA). Formaldehyde (16%,
no methanol) was obtained from Thermo Fisher Scientiﬁc (Rockford,
IL). Porcine brain L-α-phosphatidylserine (PS) and chicken egg L-α-
phosphatidylcholine (PC) were purchased from Avanti Polar Lipids
(Birmingham, AL). All other reagents were obtained from standard
suppliers.
2.2. Cell culture and treatment with agents
S49 mouse lymphoma cells were grown in suspension in Dulbecco's
Modiﬁed Eagle Medium at 37 °C (10% CO2) as explained [17].
Thapsigargin treatments (5 μM) or equivalent volumes of DMSO (0.1%
v/v) were done in culturemedium. For experiments, cells were collected
by centrifugation, washed, and suspended (0.25–3.5 × 106 cells/ml) in a
balanced saltmedium (NaCl=134mM, KCl=6.2mM, CaCl2=1.6mM,
MgCl2 = 1.2 mM, Hepes = 18.0 mM, and glucose = 13.6 mM, pH 7.4,
37 °C). Treatmentswith ionomycin (300 nM)were done in the balanced
salt medium after cell harvesting. All experiments, treatments, and incu-
bations were conducted at 37 °C unless otherwise speciﬁed. Samples
were equilibrated at the indicated temperature for at least 10 min prior
to addition of probes or treatment agents. Sample viability was assessed
by trypan blue exclusion.
2.3. Addition of exogenous PS
S49 cell plasmamembranes were enrichedwith exogenous PS using
liposomes containing 50% PS and 50% PC. Lipids were dried under nitro-
gen and resuspended in PBS (1mM ﬁnal). In order to make unilamellar
liposomes, samples were sonicated in a Misonex Sonicator 3000(Farmingdale, NY) at 2 W for 3 min. Cells were harvested as described
above and resuspended to a density of 0.5–1.5 × 106 cells/ml. Cells
were then incubated with liposomes (50 μM ﬁnal lipid concentration)
for 30 min at 37 °C, collected by centrifugation, and resuspended in
balanced salt medium for experimentation.
2.4. Fluorescence spectroscopy
Time-based ﬂuorescence intensities were assayedwith a Fluoromax
(Horiba Jobin Yvon, Edison, NJ) photon-counting spectroﬂuorometer.
Anisotropy measurements were collected with a PC-1 (ISS, Champaign,
IL) photon-counting spectroﬂuorometer equippedwithGlan–Thompson
polarizers. Continuous gentle stirring with a magnetic stir bar ensured
sample homogeneity, and temperature was maintained by a jacketed
sample chamber fed by a circulating water bath. Bandpass was set at
16 nm for anisotropymeasurements and 4 nm for all other experiments.
When necessary, ﬂuorescence emission at multiple wavelengths
was acquired by rapid sluing of monochromator mirrors. Cell samples
were treated and prepared as described above and equilibrated in the
ﬂuorometer sample chamber for at least 5 min before initiating data
acquisition.
Cell membrane hydrolysis catalyzed by sPLA2 was measured by
assaying fatty acid release using ADIFAB (65 nM ﬁnal) as described
[18]. The amount of fatty acid released was quantiﬁed by comparing
ADIFAB ﬂuorescence emission (excitation = 390 nm) at 432 and
505 nm (I432 and I505) [19] and calculating the generalized polarization
(GPADIFAB) as described [17]:
GPADIFAB ¼
I505−I432
I505 þ I432
: ð1Þ
Measurements of TMA-DPH (250 nM ﬁnal) ﬂuorescence were col-
lected with different conﬁgurations of excitation (350 nm) and emis-
sion (452 nm) polarizers in the vertical and horizontal positions after
10 min equilibration of cells with the probe. The anisotropy (r) was
then calculated from the ﬂuorescence intensity when both polarizers
were vertical (I//) andwhen the excitationwas vertical and the emission
horizontal (I⊥). Correction for differential transmission and detection at
the two polarizer positions was included (G) according to convention:
r ¼ I==−GI⊥
I== þ 2GI⊥
: ð2Þ
Merocyanine 540 (170 nM) ﬂuorescence intensity was acquired as a
function of time with excitation at 540 nm and emission at 585 nm.
Patman (250 nMﬁnal) data were collected in a similarmanner with ex-
citation at 350 nm and emission at both 435 and 500 nm (I435 and I500).
Patman spectral changeswere quantiﬁed by calculating the generalized
polarization (GP) as follows [20]:
GP ¼ I435−I500
I435 þ I500
: ð3Þ
For Patman equilibration analyses of temperature studies, time
courses of probe intensity were smoothed by nonlinear regression to
an arbitrary function (analogous to Eq. (4)) and normalized to the in-
tensity at 435 nm at 400 s to aggregate data from multiple replicate
samples. These pooled data were then ﬁt by nonlinear regression to
the following:
I ¼ A 1−e−bt
 
þ C 1−e−dt
 
þ F ð4Þ
where A and C are arbitrary scalars, b and d are rate constants, and F is
the intercept intensity. Intensities at bothwavelengthswere ﬁt together
with b and d constrained as shared parameters. Theseﬁtting parameters
were then used to calculate model parameter values (fraction of probe
Fig. 1. Effect of temperature and ionomycin on TMA-DPH anisotropy and PatmanGP. Cells
were equilibrated at the indicated temperatures for 10 min with TMA-DPH (Panel A) or
Patman (Panel B), and data were then acquired as described in Materials and methods.
Ionomycin was then added and additional data were acquired. The gray bars represent
the value of anisotropy (A) or GP (B) acquired immediately before ionomycin addition.
The black bars represent the effect of ionomycin treatment assessed at 2 min (A) or at
the GP minimum (B, generally achieved within 2 min after adding ionomycin). Error
bars represent the SE (n = 9–12 per group).
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rate of probe entering each conﬁguration) according to Eqs. (11)–(14)
in Franchino et al. [9]. Error was evaluated by using the extreme values
of the 95% conﬁdence intervals for each ﬁtting parameter generated by
nonlinear regression. Every permutation of these ﬁtting parameterswas
inputted into Franchino et al. Eqs. (11)–(14) [9] to determine the range
of possible model parameter values.
For Patman equilibration studies with ionomycin, the ionophore
was added after probe. These intensity proﬁles were ﬁt according to
an arbitrary function similar to Eq. (4) for both 435 and 500 nm with
a third exponential term (i.e. analogous to the ﬁrst term, A(1−e−bt),
in Eq. (4)) applied at the time of ionomycin addition. The rate constant
of this third exponential termwas constrained to be shared between the
435 nm and 500 nm curves. Intensity changes were assessed by the
value of the scaler from this third term.
2.5. Flow cytometry
The annexin V Alexa Fluor® 488 conjugate was used to assay PS
externalization according to manufacturer's instructions. All ﬂow
cytometry samples were immediately processed (without ﬁxation)
in a BD FACSCanto ﬂow cytometer (BD Biosciences, San Jose, CA) with
an argon excitation laser (488 nm). Emission was assessed using a
bandpass ﬁlter at 515–545 nm. Resulting histograms of annexin V
ﬂuorescence intensity were ﬁt by nonlinear regression with a function
composed of three Gaussian curves (low, medium, and high annexin V
intensities). In cases of samples labeledwith exogenous PS, fourGaussian
curves were required to ﬁt the data, and the twowith the highest means
were assigned to the “high” category. The means were constrained to be
shared among the various samples for each experiment.
2.6. Phalloidin confocal microscopy
Cells were simultaneously ﬁxed, permeabilized, and stained
with ﬂuorescent phalloidin (Alexa Fluor® 488) according to the
manufacturer's protocol. After being mounted onto slides, cells were
stained with a solution containing 165 nM phalloidin, 3.7% formalde-
hyde, 1% bovine serum albumin, and 0.1 mg/ml 1-palmitoyl-2-hy-
droxy-sn-glycero-3-phosphocholine for 20 min at 4 °C. Slides were
then washed with buffer before coverslips were mounted. Images
were collected on anOlympus (Center Valley, PA) FluoView FV 300 con-
focal laser scanning microscope using a 60× oil immersion objective
lens and 488 nm argon excitation laser.
ImageJ software was used to quantify the circularity index and size
(number of pixels) of all particles in each image [21]. Prior to analysis,
color imageswere converted to 8-bit grayscale and inverted so that par-
ticles were dark against a light background. The default algorithm in the
software package for determining background levels was used. After
subtracting this background, images were converted to 1-bit black and
white.
3. Results and discussion
3.1. Comparison of effects of temperature and ionomycin on membrane
order and hydrolysis
Experiments with the ﬂuorescent probes TMA-DPH and Patman
were conducted to assess whether cell membrane biophysical proper-
ties could be manipulated by temperature to an extent comparable to
that observed during ionophore treatment. As shown in Fig. 1A, TMA-
DPH anisotropy decreased as temperature was elevated (gray bars),
consistent with the membrane becoming more disordered as tempera-
ture was raised. Subsequent addition of ionomycin caused a further
drop in anisotropy at all temperatures (black bars), suggesting that
the two effects onmembrane order could involve differentmechanisms.
A two-way analysis of variance indicated that ionophore treatmentwasresponsible for 31.9% of the variation within the data (p b 0.0001),
temperature accounted for 24.4% of the variation (p b 0.0001), and no
signiﬁcant interaction between the two was detected (4% of total
variation; p = 0.09, n = 9–12 per group). Importantly, the effect of
temperature was comparable to the effect of addition of ionomycin
(average change in anisotropy induced by ionomycin = −0.034
units; average change by heating from 32 to 45 °C =−0.048 units, a
ratio of 0.72).
When Patman was used to assess membrane order (Fig. 1B), there
was also a signiﬁcant negative trend in Patman GP over the same tem-
perature range (gray bars), and ionomycin treatment caused a further
reduction in GP at all temperatures (black bars). Two-way analysis of
variance showed that both temperature and ionomycin effects were
signiﬁcant without interaction (temperature: p = 0.0001, 42% of
the variation; ionomycin: p b 0.0001, 2% of the variation; interaction:
p= 0.6, 0.05% of variation; n = 9–15 per group). An interesting differ-
ence from the TMA-DPH result is that in the case of Patman, the effect of
ionomycinwasmuch smaller than the effect of heating from 32 to 45 °C
(average change in GP induced by ionomycin =−0.024 units; average
change by heating from 32 to 45 °C=−0.15 units, a ratio of 0.17). This
difference between the observations with TMA-DPH and Patman
further reinforced the possibility that the effects of temperature and
ionomycin on apparent membrane order were not the same.
In summary, the results of Fig. 1 demonstrate that elevation of
temperature from 32 to 45 °C is sufﬁcient to produce a change in appar-
ent membrane order comparable to (Panel A) or greater than (Panel B)
that generated by ionomycin treatment. For that reason, untreated cells
at 32 °Cwas used as the reference point to determinewhether themem-
brane changes associated with temperature elevation could enhance
sPLA2-catalyzed hydrolysis by the same increment as ionomycin treat-
ment. Accordingly, hydrolysis at this reference point was compared to
that observed with untreated cells at 45 °C or ionomycin-treated cells at
Fig. 3. Addition of exogenous PS to plasma membrane. Cells were incubated with (black)
orwithout (gray) PS-containing liposomes and assayed for annexin V binding as described
in Materials and methods. Example ﬂow cytometry histograms show the designation of
low, medium (“med”), and high annexin V intensities.
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dence of AppD49 sPLA2 activity toward micelles is minimal in this tem-
perature range compared to the magnitude of effects of membrane
structure [3]. Fig. 2 shows example proﬁles of sPLA2-catalyzed hydrolysis
(assayed by ADIFAB GP) over time, with an increase in GP indicating fatty
acid release from the plasma membrane. As shown by the upper (black)
curve, the presence of ionomycin produced a large increase in ADIFAB
GP when sPLA2 was added (dotted line) compared to that observed in
the reference sample (middle dark gray curve). This result suggested
that the ionophore rendered the cells susceptible to attack by sPLA2 sim-
ilar to previous observations reported for 37 °C [1]. The question, then,
was whether cells at 45 °C would behave more like the 32 °C reference
or the ionomycin-treated sample. The lower (light gray) curve illustrates
that incubating the sample at 45 °Cproduced ahydrolysis proﬁle indistin-
guishable from the reference obtained at 32 °C. This result was reproduc-
ible (p = 0.1 comparing 8 samples at 45 °C to the 32 °C reference and
p b 0.0001 comparing them to the ionomycin-treated sample at 32 °C,
t-tests). Adding ionomycin to samples at 45 °C resulted in complete cell
susceptibility to hydrolysis by sPLA2 identical to the observation at
32 °C (not shown). Therefore, although raising the temperature caused
the same or greater changes in TMA-DPH and Patman ﬂuorescence as
ionomycin, only the ionophore produced a signiﬁcant increase in suscep-
tibility to sPLA2.
3.2. Direct effects of phosphatidylserine
A possible candidate for the distinction between ionomycin
treatment and temperature elevation was PS exposed on the outer
surface of the plasma membrane. It is well known that ionomycin
causes a large enhancement of PS externalization [22–24] and that
such exposure could enhance sPLA2 activity [7,18,24]. To verify the dis-
tinction between ionomycin and temperature effects on PS exposure,
measurements of the amount of PS present on the cell surface were
made using ﬂuorescent annexin V. Flow cytometry data validated that
temperature elevation from 32 to 45 °C does not alter the level of PS
on the cell surface (p = 0.3 by analysis of variance, n = 4 each at 32,
37, and 45 °C; distinguishable from ionomycin-treated positive control,
p b 0.001). To test the hypothesis that PS is the source of differences in
hydrolysis observed in Fig. 2, exogenous PS was added directly to the
outer leaﬂet of the plasma membrane. This was accomplished by
incubating cells with vesicles composed of 50% egg PC and 50% brain
PS. Successful delivery was assessed by ﬂow cytometry. Fig. 3 shows
histograms of external PS exposure for control cells (gray) and cells
incubated with vesicles containing PS (black). The enhancement ofFig. 2. Cell membrane hydrolysis by sPLA2 at 32 and 45 °C. Cells were incubated at
32 (dark gray and black) or 45 °C (light gray) for 5 min and ionomycin (black) or control
solvent (DMSO; dark and light gray) for an additional 5 min prior to data acquisition.
Hydrolysis was assayed using ADIFAB (added at t = 0 on graph) as described inMaterials
and methods. Secretory PLA2 was added at the dotted line. Data were numerically
displaced vertically for clarity of presentation.annexin staining at both medium and high intensities shown in Fig. 3
was reproducible (p = 0.02 for each, t test). Control experiments
veriﬁed that addition of exogenous PS did not alter membrane order
as detected by TMA-DPH anisotropy nor the ability of ionomycin to sub-
sequently reduce it (i.e. as in Fig. 1; vesicles contributed 6% of the vari-
ation, p= 0.4; ionomycin contributed 28% of the variation, p= 0.001;
interaction contributed 0.4% of the variation, p=0.6; two-way analysis
of variance, n = 5 per group).
After incubation of cells with these vesicles, samples were assayed
for susceptibility to sPLA2 by repeating the experiments of Fig. 2. Two-
way analysis of variance indicated that there were no signiﬁcant effects
of either temperature or the presence of exogenously-added PS on the
amount of hydrolysis observed upon addition of sPLA2 (p=0.9 for tem-
perature, 0.3 for PS, and 0.8 for interaction, in combination accounted
for only 3% of the variation, n = 5–14 per group). It could be argued
that hydrolytic susceptibility was not affected because the bulk of the
annexin V positive cells in Fig. 3 was stained with lower intensity than
seen in ionomycin-treated samples (largely staining at the “high”
intensity) [7]. To investigate this possibility, parallel annexin V and sus-
ceptibility assays were compared to determine if the percentage of cells
with “high” intensity staining correlated with the amount of fatty acid
release from the membrane. Linear regression revealed that there was
no signiﬁcant correlation between ADIFAB GP increase (hydrolysis)
and cells with “high” intensity annexin V staining in control cells or
cells loaded with exogenous PS (p = 0.4, r2 = 0.2 and 0.3, r2 = 0.3
respectively, n = 5 per group).3.3. Differences detected by Patman, TMA-DPH, and MC540 ﬂuorescence
intensity
Since the presence of PS on the outer leaﬂet of the cellmembrane did
not appear to be the distinction between ionomycin treatment and
temperature elevation, attention was directed toward a more detailed
analysis of the biophysical properties of the bilayer. First, the possibility
that the distinction was due to ultrastructural changes such as cell
shrinkage and microparticle shedding from the plasma membrane
was considered. These effects are known to occur in S49 cells and result
from osmotic effects due to opening of calcium-activated potassium
channels during ionophore treatment [11,25–27]. To test this possibility,
the experiments of Figs. 2 and 3 were repeated in the presence of 1 mM
quinine, an inhibitor of calcium-activated potassiumﬂux. Quinine had no
effect on the ability of ionomycin to induce susceptibility even though it
has been shown to reduce the release of microparticles by 80% in S49
cells [27]. This result is consistent with similar ﬁndings from studies
with erythrocytes [11].
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membrane. Previous studies with Patman revealed that examining the
time course of probe equilibration can detect biophysical membrane
changes that are otherwise indistinguishable by endpoint measure-
ments of anisotropy or GP [6,9]. In those studies, a minimum model
that could account for the equilibration patterns was identiﬁed. This
model required two membrane-bound conﬁgurations for Patman that
differ in their rates of equilibration. Molecular dynamics simulations
using a related probe, Laurdan, also predicted that these probes might
exist in two equilibrium conﬁgurations and identiﬁed possible molecu-
lar bases for the two [28]. From the kinetics of Patman equilibration at
two wavelengths (435 and 500 nm), the model generates the propor-
tion of Patman in each conﬁguration, the relative environmental polar-
ity of each, and the equilibration rate of each. Accordingly, Patman
emission intensities at both wavelengths were collected over time for
at least 500 s after the probe was added to cell samples at various tem-
peratures between 32 and 45 °C. The data were ﬁt by nonlinear regres-
sion with an arbitrary function analogous to Eq. (4) and analyzed
according to the model [6,9]. Similar to results reported previously for
the effect of temperature on artiﬁcial membranes [9], the only model
parameter consistently altered by temperature was the environmental
polarity of one of the conﬁgurations. This polarity increased from
0.336 ± 0.052 to 0.443 ± 0.002 arbitrary units (mean ± 95% conﬁ-
dence interval) from low tohigh temperature. Overlap of the conﬁdence
intervals for all other model parameters indicated that they were not
affected by temperature.
In order to determine whether calcium ionophore treatment had
the same effect on the membrane as temperature, an experimental
protocol was adopted in which ionomycin was added midway during
Patman's equilibration (Fig. 4A). This procedure was used to leverageFig. 4.Membrane probe intensity changes after ionomycin treatment or temperature ele-
vation. Panel A: Patman emission intensity was assayed at 435 (black) and 500 nm (gray)
following Patman addition to the cell sample (time 0 on the graph) 38 °C. Ionomycin was
added at the dotted line. Panel B: Patman emission intensity was quantiﬁed from proﬁles
such as that shown in Panel A at both 435 (black) and 500 nm (gray), before and after
ionomycin treatment, and at temperatures ranging from 32 to 45 °C. Bars represent the
average change in these intensities after ionomycin treatment or the difference between
average sample intensity at high (40–45 °C) and low temperatures (32–35 °C). Panels C
and D: Merocyanine 540 (C) and TMA-DPH (D) intensities were assayed at temperatures
ranging from 32 to 45 °C as described in Materials and methods. The bars represent the
average change in these intensities following 2 min of treatment with ionomycin or the
difference between the average intensities at high (40–45 °C) and low temperatures
(32–35 °C). Error bars represent the SE (n = 9–34 per group).the precision of before- and after-treatment measurements on the
same sample since the effects of ionomycin on Patman ﬂuorescence
were subtle (i.e. the change in GPwas small, compared to effects of tem-
perature, Fig. 1B). Surprisingly, addition of ionomycin caused an in-
crease in the intensity at both wavelengths. This result was
reproducible (Fig. 4B) and sharply contrasted themore conventional re-
sult observed with temperature (in which total intensity remains con-
stant and differences in membrane order are reﬂected by symmetrical
but opposite changes at 435 and 500 nm). Since Patman ﬂuorescence
in aqueous solution is negligible [9], these results suggest that
ionomycin treatment increases the capacity of the membrane to bind
the probe. Importantly, these changes in Patman emission occurred
within a few minutes (rate = 0.011 ± 0.003 s−1, half-time of 61 s) a
time frame during which biological effects of ionomycin on S49 cells
are known to occur [1,27], but preceding latent effects on membrane
permeability that would obscure interpretations of membrane probe
ﬂuorescence (generally beyond10min based on control imaging exper-
iments and [6]).
To test the generality of this observation, we compared two other
charged membrane probes with modest water solubility for which
binding should depend on membrane biophysics (MC540 [10,29–31]
and TMA-DPH). As shown in Fig. 4C and D, temperature did not
inﬂuence the total ﬂuorescence intensity of either TMA-DPH or
MC540, indicating that temperature probably did not alter the amount
of probe bound. In contrast, ionomycin treatment had strong effects
on the intensity of both probes (see also previous report of the effect
of ionomycin on MC540, [1]). Thus, it appeared that an important dis-
tinction between temperature and ionomycin treatment was that the
latter somehow caused the membrane to have higher afﬁnity for these
membrane probes.
The results of Fig. 4 suggest that ionomycin treatment destabilizes
the membrane in a way that reduces interactions among neighboring
lipids thus increasing their spacing and allowing for increased likelihood
of probe molecules intercalating among them. Moreover, this destabili-
zation was different from the enhanced ﬂuidity and decreased lipid
order associated with a rise in temperature. This idea corroborates
prior interpretations that MC540 can be used as an assay of the spacing
among membrane lipids [10,29–31]. A reduction in the strength of in-
teractions among neighboring phospholipids has been invoked previ-
ously as an explanation for the increase in sPLA2 activity associated
with certain structural heterogeneities in artiﬁcial membranes and
human erythrocytes [3,32–34]. The idea is that suchmembrane instabil-
ities would allow greater membrane deformability and an increased
probability that membrane lipids could protrude sufﬁciently above the
average bilayer surface to enter the active site of bound sPLA2 and behy-
drolyzed [6,13,14]. Thus, we conclude that these comparisons between
ionomycin treatment and temperature elevation reveal that increased
membrane ﬂuidity and lipid disorder are not sufﬁcient to induce
susceptibility to sPLA2 unless accompanied by greater average spacing
between neighboring lipids.
3.4. Comparison of temperature and ionomycin effects on actin cytoskeleton
The remaining question is: what effect of elevated intracellular calci-
um would cause such changes to occur in the bilayer? Extracellular
exposure of PS might have provided an explanation for greater lipid
spacing because of charge exclusion effects from the anionic lipid, but
this was rejected based on the data with exogenous PS described
above. An obvious alternative is that the instability reﬂects a loss of
interactions between the plasma membrane and the cytoskeleton.
This hypothesis is plausible because actin and actin-associated proteins
are known to be cleaved/altered during apoptosis [35–38]. Further-
more, ionomycin treatment has recently been shown to disrupt the
actin cytoskeleton in S49 cells resulting in destabilization of the bilayer
sufﬁcient to accommodate microparticle shedding from the plasma
membrane [27]. Biophysically, it is well established that the actin
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elasticity and thereby creating resistance to deformations such as
those associated with cell shape change, microparticle release, and in
this case, lipid protrusions that can result in hydrolysis by sPLA2.
If disruption of the actin cytoskeleton is directly relevant to the activ-
ity of sPLA2 described in this study, three observations must be true:
1) actin disruption would occur with treatments that also cause the
membrane to become susceptible, 2) actin disruption would not occur
with an elevation of temperature, and 3) blocking disruption of actin
would prevent the ability of ionomycin to induce hydrolysis by sPLA2.
Unfortunately, only the ﬁrst two tests were feasible with S49 cells.
Experimental means to directly prevent disruption of the cytoskeleton
by ionomycin were not accessible (e.g. calpain inhibitors did not
prevent ionomycin-stimulated actin disruption, presumably because
of redundant pathways [40]).
To investigate the possibility that ionomycin causes cytoskeletal
alterations while temperature does not, F-actin was stained with ﬂuo-
rescent phalloidin and imaged via confocal microscopy. Fig. 5 shows
example images of control cells (Panel A), ionomycin-treated cells
(Panel B), and cells incubated at 45 °C without ionomycin (Panel C).
Fibrous actin ﬁlaments were prominent in control cells, and Panel B
shows a loss of these ﬁlaments and the appearance of large circular
aggregates of densely-staining material after ionomycin treatment.
Cells incubated at 45 °C for 10 min (Fig. 5C) appeared more like control
than ionomycin-treated cells.
ImageJ software was used to calculate the circularity index of all
particles in such images as explained in Materials and methods. As
shown by the histogram in Fig. 6A, ionomycin treatment reproducibly
produced elevated numbers of particles with high circularity (N0.85,
Fig. 6B). Previous work has demonstrated that ionomycin stimulates
shedding of plasma membrane microparticles to the extracellular ﬂuid
[27]. To test the possibility that these highly circular densely-staining
particles represented structures associated with the process of particle
formation or release, the experiments of Fig. 5 were repeated in the
presence of quinine, which is known to prevent microparticle shedding
[11,25,27,41] without affecting plasma membrane susceptibility to
sPLA2 (Ref. [11] and veriﬁed by control experiments on S49 cells, not
shown). Fig. 6A demonstrates that the highly- circular particles released
with ionomycin treatment were eliminated when quinine was also
present (dotted line). Hence, their contribution to quantitative analysis
of the images couldmostly be excluded by ignoring particles with circu-
larity N0.85. Fig. 6B displays histograms of the size of particles with
circularity b0.85. Based on this analysis, the effect of ionomycin on
actin ﬁlaments separate from changes blockable with quinine was
detected by an elevation in the number of particles in the size range of
22 to 44 pixels. At the image magniﬁcation used for the analysis, these
particles would correspond to a size of ~0.9 to ~1.8 μm2. As shown in
Fig. 6C, both the number of particles in this range and the effect ofFig. 5. Images of phalloidin staining of F-actin in control cells (Panel A), ionomycin-treated cells
the indicated temperature prior to treating for 5 min without (DMSO) or with ionomycin befor
microscopy (see Materials and methods). These images were collected with a 60× objective wionomycin did not vary with temperature (effect of ionomycin = 33%
of the variation with p= 0.0003, effect of temperature= 8% of the var-
iation with p = 0.16, and no signiﬁcant interaction between the two:
p = 0.98, n = 2–10 per group). It should be noted that the data in
Fig. 6B indicated that only about 44% of the difference between the
gray and black bars in Fig. 6C would be completely free from the effect
of microparticle release. Nevertheless, the overall effect of ionomycin
was still signiﬁcant even when the effect size was accordingly reduced
(p = 0.0003 by paired t-test comparing ionomycin samples to their
own control samples pooled for all three temperatures, n = 13). This
increase in small particles coupled with the loss of stained ﬁbers in
the images after ionomycin treatment (Fig. 5B) conﬁrmed previous
reports that elevated intracellular calcium produces fragmentation of
actin ﬁlaments [27,42,43]. Importantly, the absence of such effects
with temperature variation supported the idea that these cytoskeletal
alterations may be responsible for plasma membrane changes that
facilitate hydrolysis by sPLA2.
To further investigate the connection between actin-severing and
plasmamembrane susceptibility to sPLA2, changes in the actin cytoskel-
eton were investigated during TG-induced apoptosis. Previous studies
have indicated that S49 cells begin to become susceptible to hydrolysis
within an hour of exposure to TG, reaching a maximum at 3 h [6]. As
shown in Fig. 7, treatment with TG for at least 1 h also caused an in-
crease in the number of low-circularity particles (b0.85) falling within
the 0.9–1.8 μm2 range (p= 0.004, paired t-test, n = 5). The magnitude
of this increase in small particles was about half that observed in
ionomycin-treated samples (Fig. 6), presumably because ionomycin
affects the entire population in a more synchronized manner than
does TG [1,6].
4. Conclusion
Prior to this study, the understanding of the action of sPLA2 on
eukaryotic cells was that membrane order is critical and apparently suf-
ﬁcient to induce rapid hydrolysis [1,2,6,18]. An exception is the human
group IIA isoform, which appears to be governed almost entirely by
membrane oxidation in S49 cells [44]. Moreover externalization of PS
appears to function as a signiﬁcant enhancer but is insufﬁcient to func-
tion alone as the regulator of hydrolysis [2,18]. This study reﬁnes those
statements with the following four conclusions. First, a simple increase
in the motion of the lipids precipitated directly by raising the tempera-
ture does not render the membrane susceptible to sPLA2 even though
steady state ﬂuorescence data suggest that it produces the same effect
on membrane properties as perturbations (such as ionomycin) that do
promote hydrolysis (Figs. 1 and 2). Second, although elevation of
temperature differed from ionomycin by not causing exposure of PS,
that difference is not the determinant of hydrolysis since a combination
of elevated temperature plus exposed PS did not induce susceptibility to(Panel B), and cells incubated at 45 °C (Panel C). Cells were harvested and equilibrated at
e being mounted onto slides, stained with ﬂuorescent phalloidin, and imaged by confocal
ith a 3× digital zoom.
Fig. 6. Effect of temperature and ionomycin on F-actin particle size. Images such as those in
Fig. 5 were analyzed using ImageJ as described in Materials and methods. Gray lines and
bars represent control samples, solid black lines and bars represent samples treated
with ionomycin, and dotted black lines represent samples treated with 1 mM quinine
for 10 min prior to addition of ionomycin. Panel A: Histogram of particle circularity
(≥0.7, n = 3). Panel B: Histogram of the logarithm of particle size for particles with
circularity b0.85 (n = 3). Panel C: The number of particles with circularity b0.85 and in
the size range between 22 and 44 pixelswas calculated for samples at the indicated temper-
atures (n = 2–10) and normalized to the total number of particles with circularity b0.85.
Fig. 7.Actin fragmentation during TG-induced apoptosis. Panels A and B are confocal images
of phalloidin-stained F-actin after 4 h of treatment with DMSO (vehicle control, Panel A) or
TG (Panel B). Samples were prepared as in Fig. 5 without the digital zoom. Panel C: Images
were analyzed as in Fig. 6, and the fraction of particles with circularity b0.85 in the size
range of 22–44 pixels was calculated. The gray bar represents control samples (n = 5),
and the black bar represents samples treated for 1–5 h with TG (n = 5; each experimental
sample represents the average from multiple images at multiple time points within the
1–5 h; linear regression revealed no time trend in that range, p= 0.9, r2= 0.0007).
2613E. Gibbons et al. / Biochimica et Biophysica Acta 1838 (2014) 2607–2614sPLA2. Third, measurements of Patman, MC540, and TMA-DPH ﬂuores-
cence intensities identiﬁed a distinction between the effect of tempera-
ture and ionomycin. In the former case, the membrane environment
detected by the probe became more polar as temperature increased.
In the latter, treatments that promote hydrolysis also enhanced the
insertion of probes into the membrane (Fig. 4). This effect on probe
partitioning has been hypothesized to reﬂect a reduction in membrane
lipid-neighbor interactions which could raise the probability of vertical
lipid ﬂuctuations in the membrane sufﬁcient to facilitate binding of
substrate to the enzyme active site [6,13,14]. Fourth, based on the data
of Figs. 5–7, it is suggested that the biochemical basis for the altered
probe distribution is due to disruption of the actin cytoskeleton. Since
it was not possible to block the effect of ionomycin to disrupt the
cytoskeleton, this fourth conclusion must remain a proposal for further
testing in the future.References
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